Clonazepam is the most widely prescribed anxiolytic in psychiatry, which is well tolerated and is rarely associated with cutaneous adverse drug reactions. This is a case of a 31-year-old male businessman diagnosed with generalized anxiety disorder (GAD), who later developed skin lesions after oral consumption of clonazepam. Dermatological consultation was sought, and the patient was diagnosed with a case of clonazepam-induced hypersensitivity reaction, corroborated by the blood investigations, oral drug challenge test, and the histopathological skin biopsy report. The patient was managed with corticosteroids, anxiolytic drugs other than clonazepam, and a supportive approach. This is a unique case of a hypersensitivity reaction due to clonazepam, which will be helpful for future research and clinical practice.
No takes yet. Share an insight, caveat, or question.
Borah et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: